Login to Your Account



AstraZeneca Continues Buying Spree With $150M Purchase

By Nuala Moran


Friday, February 2, 2007
LONDON - AstraZeneca plc continued its hyperactive round of licensing and acquisitions, agreeing to buy Arrow Therapeutics Ltd., an antiviral specialist, for $150 million cash. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription